Turnstone Biologics Corp.
TSBXDelisted Aug 11, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764974
Turnstone Biologics Corp. was delisted on Aug 11, 2025; its insiders filed their last Form 4 on Aug 12, 2025; 23 institutions reported holding it in 13F filings for Q2 2025, worth $3.03M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Turnstone Biologics Corp. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +7 vs. Q1 2024
- Shares held
- 12.7M
- −647.7K (−4.9%) vs. Q1 2024
- Total value
- $33.3M
- −$1.70M (−4.9%) vs. Q1 2024
- New holders
- 16
- 11 more added
- Sold out
- 9
- 14 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TSBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 23 | $3.03M |
| Q1 2025 | 23 | $4.26M |
| Q4 2024 | 28 | $5.51M |
| Q3 2024 | 24 | $6.37M |
| Q2 2024 | 47 | $33.3M |
| Q1 2024 | 40 | $35.0M |
| Q4 2023 | 36 | $33.1M |
| Q3 2023 | 35 | $48.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Turnstone Biologics Corp.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 3,099,265 | $8.12M | 0.17% | 00.0% | Unchanged |
| FMR LLC | 1,135,249 | $2.97M | 0.00% | −439,577−27.9% | Reduced |
| Point72 Asset Management, L.P. | 1,118,588 | $2.93M | 0.01% | −65,300−5.5% | Reduced |
| PFM Health Sciences, LP | 932,348 | $2.44M | 0.13% | +11,372+1.2% | Added |
| Bank of America Corp | 910,781 | $2.39M | 0.00% | +11,408+1.3% | Added |
| Takeda Pharmaceutical Co Ltd | 895,824 | $2.35M | 1.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 684,633 | $1.79M | 0.00% | −2040.0% | Reduced |
| Vanguard Group Inc | 578,995 | $1.52M | 0.00% | +209,319+56.6% | Added |
| 72 Investment Holdings, LLC | 549,980 | $1.44M | 3.62% | −10.0% | Reduced |
| Sectoral Asset Management Inc | 517,648 | $1.36M | 0.55% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 464,821 | $1.22M | 0.01% | +95,041+25.7% | Added |
| Eventide Asset Management, LLC | 458,317 | $1.20M | 0.02% | 00.0% | Unchanged |
| Zimmer Partners, LP | 216,138 | $566.3K | 0.01% | +37,112+20.7% | Added |
| FIL Ltd | 192,657 | $504.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 125,857 | $329.7K | 0.00% | +125,857 | New |
| Barclays PLC | 115,978 | $303.9K | 0.00% | −5,403−4.5% | Reduced |
| Northern Trust Corp | 94,234 | $246.9K | 0.00% | −5,241−5.3% | Reduced |
| Goldman Sachs Group Inc | 73,288 | $192.0K | 0.00% | +73,288 | New |
| Geode Capital Management, LLC | 71,952 | $188.6K | 0.00% | −166,132−69.8% | Reduced |
| Balyasny Asset Management LLC | 53,682 | $140.6K | 0.00% | +20,936+63.9% | Added |
| Susquehanna International Group, LLP | 51,293 | $134.4K | 0.00% | +27,922+119.5% | Added |
| Kathleen S. Wright Associates Inc. | 42,553 | $111.5K | 0.05% | 00.0% | Unchanged |
| BlackRock Inc. | 41,344 | $108.3K | 0.00% | −622,060−93.8% | Reduced |
| Jane Street Group, LLC | 36,609 | $95.9K | 0.00% | +36,609 | New |
| Y-Intercept (Hong Kong) Ltd | 35,771 | $93.7K | 0.01% | +35,771 | New |
| Centiva Capital, LP | 25,225 | $66.1K | 0.00% | +25,225 | New |
| Bridgeway Capital Management, LLC | 24,900 | $65.2K | 0.00% | −35,000−58.4% | Reduced |
| Citigroup Inc | 24,825 | $65.0K | 0.00% | +21,886+744.7% | Added |
| Qube Research & Technologies Ltd | 19,025 | $49.8K | 0.00% | +19,025 | New |
| Morgan Stanley | 18,759 | $49.1K | 0.00% | −4,835−20.5% | Reduced |
| Squarepoint Ops LLC | 15,018 | $39.3K | 0.00% | +15,018 | New |
| Virtu Financial LLC | 13,954 | $37.0K | 0.00% | +13,954 | New |
| O'Shaughnessy Asset Management, LLC | 13,737 | $36.0K | 0.00% | +13,737 | New |
| SEI Investments Co | 11,882 | $31.1K | 0.00% | +11,882 | New |
| Tower Research Capital LLC (TRC) | 10,502 | $27.5K | 0.00% | +7,093+208.1% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 8,135 | $21.3K | 0.00% | +8,135 | New |
| JPMorgan Chase & Co | 6,841 | $17.9K | 0.00% | +671+10.9% | Added |
| Catalyst Funds Management Pty Ltd | 3,900 | $10.2K | 0.00% | +3,900 | New |
| Russell Investments Group, Ltd. | 2,445 | $6.41K | 0.00% | +2,445 | New |
| UBS Group AG | 1,551 | $4.06K | 0.00% | −17,506−91.9% | Reduced |
| Nordwand Advisors, LLC | 1,500 | $3.93K | 0.00% | +1,500 | New |
| Rhumbline Advisers | 860 | $2.25K | 0.00% | −8,249−90.6% | Reduced |
| Macquarie Group Ltd | 789 | $2.07K | 0.00% | +789 | New |
| New York State Common Retirement Fund | 125 | $328 | 0.00% | −18,717−99.3% | Reduced |
| Nisa Investment Advisors, LLC | 54 | $141 | 0.00% | +24+80.0% | Added |
| Royal Bank of Canada | 11 | $0 | 0.00% | −340−96.9% | Reduced |
| CWM, LLC | 49 | $0 | 0.00% | +49 | New |
| State Street Corp | 0 | $0 | 0.00% | −38,491−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −34,443−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −7,616−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −5,013−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −1,755−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −796−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −630−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −205−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −178−100.0% | Sold out |